Rank | Gene Set | Z-score |
---|---|---|
1 | neuronal action potential propagation (GO:0019227) | 8.18601470 |
2 | neuromuscular process controlling posture (GO:0050884) | 7.50881603 |
3 | response to parathyroid hormone (GO:0071107) | 6.81977192 |
4 | actin-myosin filament sliding (GO:0033275) | 5.95382386 |
5 | muscle filament sliding (GO:0030049) | 5.95382386 |
6 | cellular response to nitric oxide (GO:0071732) | 5.69807696 |
7 | sarcoplasmic reticulum calcium ion transport (GO:0070296) | 5.40671007 |
8 | regulation of glucocorticoid secretion (GO:2000849) | 5.20594911 |
9 | actin-mediated cell contraction (GO:0070252) | 4.99453909 |
10 | sarcomere organization (GO:0045214) | 4.74565761 |
11 | synaptic vesicle exocytosis (GO:0016079) | 4.44532758 |
12 | respiratory system process (GO:0003016) | 4.41146521 |
13 | regulation of corticosteroid hormone secretion (GO:2000846) | 4.38101923 |
14 | myofibril assembly (GO:0030239) | 4.36040104 |
15 | response to nitric oxide (GO:0071731) | 4.34706154 |
16 | regulation of synaptic vesicle exocytosis (GO:2000300) | 4.21577185 |
17 | negative regulation of amino acid transport (GO:0051956) | 4.20513872 |
18 | labyrinthine layer development (GO:0060711) | 4.20407140 |
19 | regulation of relaxation of muscle (GO:1901077) | 4.19244121 |
20 | cardiac muscle contraction (GO:0060048) | 4.17317710 |
21 | striated muscle contraction (GO:0006941) | 4.12878692 |
22 | cellular response to reactive nitrogen species (GO:1902170) | 4.09368346 |
23 | regulation of energy homeostasis (GO:2000505) | 4.04805275 |
24 | melanin biosynthetic process (GO:0042438) | 4.03141288 |
25 | cardiac myofibril assembly (GO:0055003) | 3.98436274 |
26 | skeletal muscle contraction (GO:0003009) | 3.97244227 |
27 | regulation of skeletal muscle contraction (GO:0014819) | 3.95384490 |
28 | synaptic vesicle docking involved in exocytosis (GO:0016081) | 3.94050835 |
29 | synaptic vesicle maturation (GO:0016188) | 3.89840443 |
30 | response to stimulus involved in regulation of muscle adaptation (GO:0014874) | 3.86160495 |
31 | actin filament-based movement (GO:0030048) | 3.84660073 |
32 | ATP hydrolysis coupled proton transport (GO:0015991) | 3.76849247 |
33 | energy coupled proton transmembrane transport, against electrochemical gradient (GO:0015988) | 3.76849247 |
34 | regulation of glutamate secretion (GO:0014048) | 3.76464050 |
35 | creatine metabolic process (GO:0006600) | 3.76043839 |
36 | glutamate secretion (GO:0014047) | 3.74361036 |
37 | melanin metabolic process (GO:0006582) | 3.73361718 |
38 | response to muscle activity (GO:0014850) | 3.71001708 |
39 | short-term memory (GO:0007614) | 3.70383388 |
40 | regulation of cell communication by electrical coupling (GO:0010649) | 3.67410429 |
41 | regulation of actin filament-based movement (GO:1903115) | 3.63575925 |
42 | regulation of short-term neuronal synaptic plasticity (GO:0048172) | 3.60493114 |
43 | regulation of synaptic vesicle transport (GO:1902803) | 3.57118168 |
44 | actomyosin structure organization (GO:0031032) | 3.54007334 |
45 | transferrin transport (GO:0033572) | 3.53405808 |
46 | C4-dicarboxylate transport (GO:0015740) | 3.52265169 |
47 | NADH metabolic process (GO:0006734) | 3.48311511 |
48 | negative regulation of synaptic transmission, GABAergic (GO:0032229) | 3.42584500 |
49 | detection of temperature stimulus involved in sensory perception (GO:0050961) | 3.40989326 |
50 | detection of temperature stimulus involved in sensory perception of pain (GO:0050965) | 3.40989326 |
51 | iron coordination entity transport (GO:1901678) | 3.39272040 |
52 | response to hyperoxia (GO:0055093) | 3.36746576 |
53 | response to increased oxygen levels (GO:0036296) | 3.36746576 |
54 | cardiac muscle hypertrophy (GO:0003300) | 3.31905951 |
55 | ferric iron transport (GO:0015682) | 3.28107466 |
56 | trivalent inorganic cation transport (GO:0072512) | 3.28107466 |
57 | response to pheromone (GO:0019236) | 3.19520523 |
58 | activation of protein kinase A activity (GO:0034199) | 3.17787968 |
59 | negative regulation of dendrite morphogenesis (GO:0050774) | 3.17013009 |
60 | adult feeding behavior (GO:0008343) | 3.16675720 |
61 | regulation of the force of heart contraction (GO:0002026) | 3.16637749 |
62 | muscle contraction (GO:0006936) | 3.16100672 |
63 | glycogen catabolic process (GO:0005980) | 3.16099994 |
64 | regulation of alpha-amino-3-hydroxy-5-methyl-4-isoxazole propionate selective glutamate receptor act | 3.14711043 |
65 | macroautophagy (GO:0016236) | 3.14388809 |
66 | striated muscle hypertrophy (GO:0014897) | 3.13186212 |
67 | plasma membrane repair (GO:0001778) | 3.12480023 |
68 | adult walking behavior (GO:0007628) | 3.11802861 |
69 | negative regulation of metanephros development (GO:0072217) | 3.11271108 |
70 | secondary metabolite biosynthetic process (GO:0044550) | 3.09231195 |
71 | response to acidic pH (GO:0010447) | 3.09008659 |
72 | positive regulation of calcium ion transmembrane transporter activity (GO:1901021) | 3.05447620 |
73 | negative regulation of neurotransmitter secretion (GO:0046929) | 3.02608280 |
74 | carnitine shuttle (GO:0006853) | 3.01160124 |
75 | response to inactivity (GO:0014854) | 3.00684086 |
76 | positive regulation of autophagy (GO:0010508) | 3.00210387 |
77 | L-methionine biosynthetic process from methylthioadenosine (GO:0019509) | 2.96810500 |
78 | protein localization to synapse (GO:0035418) | 2.95154380 |
79 | regulation of steroid hormone secretion (GO:2000831) | 2.93875320 |
80 | cullin deneddylation (GO:0010388) | 2.93590440 |
81 | glucan catabolic process (GO:0009251) | 2.93513052 |
82 | neurotransmitter-gated ion channel clustering (GO:0072578) | 2.92567704 |
83 | regulation of calcineurin-NFAT signaling cascade (GO:0070884) | 2.92268534 |
84 | SCF-dependent proteasomal ubiquitin-dependent protein catabolic process (GO:0031146) | 2.91929879 |
85 | membrane depolarization during action potential (GO:0086010) | 2.91848789 |
86 | neurotransmitter secretion (GO:0007269) | 2.91134136 |
87 | muscle system process (GO:0003012) | 2.88090664 |
88 | regulation of striated muscle contraction (GO:0006942) | 2.85777029 |
89 | positive regulation of calcium ion-dependent exocytosis (GO:0045956) | 2.85243064 |
90 | muscle hypertrophy (GO:0014896) | 2.84552202 |
91 | cellular polysaccharide catabolic process (GO:0044247) | 2.83322705 |
92 | dicarboxylic acid biosynthetic process (GO:0043650) | 2.83085852 |
93 | positive regulation of excitatory postsynaptic membrane potential (GO:2000463) | 2.82469613 |
94 | detection of temperature stimulus (GO:0016048) | 2.79861869 |
95 | regulation of transforming growth factor beta1 production (GO:0032908) | 2.78970115 |
96 | amino acid salvage (GO:0043102) | 2.78656096 |
97 | L-methionine salvage (GO:0071267) | 2.78656096 |
98 | L-methionine biosynthetic process (GO:0071265) | 2.78656096 |
99 | regulation of mesenchymal to epithelial transition involved in metanephros morphogenesis (GO:0003339 | 2.78452963 |
100 | locomotory exploration behavior (GO:0035641) | 2.77447771 |
101 | calcium-mediated signaling using intracellular calcium source (GO:0035584) | 2.77240575 |
102 | neuronal action potential (GO:0019228) | 2.76959289 |
103 | regulation of cardiac muscle contraction by regulation of the release of sequestered calcium ion (GO | 2.76593426 |
104 | negative regulation of potassium ion transmembrane transporter activity (GO:1901017) | 2.75360268 |
105 | regulation of N-methyl-D-aspartate selective glutamate receptor activity (GO:2000310) | 2.74554807 |
106 | cardiac muscle tissue morphogenesis (GO:0055008) | 2.74189320 |
107 | regulation of ventricular cardiac muscle cell membrane repolarization (GO:0060307) | 2.74047647 |
108 | cell communication by electrical coupling involved in cardiac conduction (GO:0086064) | 2.74037584 |
109 | regulation of appetite (GO:0032098) | 2.70960840 |
110 | cell communication by electrical coupling (GO:0010644) | 2.69651356 |
111 | relaxation of cardiac muscle (GO:0055119) | 2.69610942 |
112 | regulation of glutamate receptor signaling pathway (GO:1900449) | 2.69001939 |
113 | positive regulation of ryanodine-sensitive calcium-release channel activity (GO:0060316) | 2.67737631 |
114 | muscle cell cellular homeostasis (GO:0046716) | 2.67661496 |
115 | regulation of calcium ion transmembrane transport (GO:1903169) | 2.66030752 |
116 | regulation of calcium ion transmembrane transporter activity (GO:1901019) | 2.66030752 |
117 | regulation of ryanodine-sensitive calcium-release channel activity (GO:0060314) | 2.65969186 |
118 | phagosome maturation (GO:0090382) | 2.65959304 |
119 | skeletal muscle fiber development (GO:0048741) | 2.64370219 |
120 | axonal fasciculation (GO:0007413) | 2.64161083 |
121 | muscle tissue morphogenesis (GO:0060415) | 2.63620360 |
122 | regulation of cardiac muscle contraction by calcium ion signaling (GO:0010882) | 2.63377604 |
123 | tricarboxylic acid cycle (GO:0006099) | 2.62762562 |
124 | gluconeogenesis (GO:0006094) | 2.62358830 |
125 | negative regulation of protein localization to cell surface (GO:2000009) | 2.62343610 |
126 | clathrin coat assembly (GO:0048268) | 2.61676325 |
127 | proteasome assembly (GO:0043248) | 2.61329659 |
128 | cell communication involved in cardiac conduction (GO:0086065) | 2.61086170 |
129 | vocalization behavior (GO:0071625) | 2.60783993 |
130 | polysaccharide catabolic process (GO:0000272) | 2.60341616 |
131 | protein deneddylation (GO:0000338) | 2.60296872 |
132 | fatty acid transmembrane transport (GO:1902001) | 2.59085784 |
133 | regulation of amino acid transport (GO:0051955) | 2.57560008 |
134 | positive regulation of synaptic transmission, dopaminergic (GO:0032226) | 2.57498682 |
135 | regulation of atrial cardiac muscle cell membrane depolarization (GO:0060371) | 2.56859034 |
136 | membrane depolarization during cardiac muscle cell action potential (GO:0086012) | 2.56201099 |
137 | L-phenylalanine metabolic process (GO:0006558) | 2.55125349 |
138 | erythrose 4-phosphate/phosphoenolpyruvate family amino acid metabolic process (GO:1902221) | 2.55125349 |
139 | positive regulation of gluconeogenesis (GO:0045722) | 2.55075233 |
140 | negative regulation of organic acid transport (GO:0032891) | 2.54480753 |
141 | heart contraction (GO:0060047) | 2.54404593 |
142 | heart process (GO:0003015) | 2.54404593 |
143 | synaptic transmission, glutamatergic (GO:0035249) | 2.51834315 |
144 | regulation of neurotransmitter secretion (GO:0046928) | 2.51565603 |
145 | regulation of synapse structural plasticity (GO:0051823) | 2.50205395 |
146 | cardiac muscle adaptation (GO:0014887) | 2.49829418 |
147 | cardiac muscle hypertrophy in response to stress (GO:0014898) | 2.49829418 |
148 | muscle hypertrophy in response to stress (GO:0003299) | 2.49829418 |
149 | relaxation of muscle (GO:0090075) | 2.49788007 |
150 | negative regulation of neurotransmitter transport (GO:0051589) | 2.48298165 |
151 | negative regulation of cation channel activity (GO:2001258) | 2.48057729 |
152 | regulation of feeding behavior (GO:0060259) | 2.48012513 |
153 | negative regulation of amine transport (GO:0051953) | 2.45832153 |
154 | fatty acid beta-oxidation using acyl-CoA oxidase (GO:0033540) | 2.45723521 |
155 | response to epinephrine (GO:0071871) | 2.45244331 |
156 | regulation of release of sequestered calcium ion into cytosol by sarcoplasmic reticulum (GO:0010880) | 2.43654416 |
157 | ADP metabolic process (GO:0046031) | 2.43168280 |
158 | positive regulation of membrane potential (GO:0045838) | 2.42867901 |
159 | positive regulation of amino acid transport (GO:0051957) | 2.41707759 |
160 | presynaptic membrane organization (GO:0097090) | 2.41378441 |
161 | myotube cell development (GO:0014904) | 2.40929713 |
162 | negative regulation of fibrinolysis (GO:0051918) | 2.40631715 |
163 | cardiac muscle cell development (GO:0055013) | 2.40609493 |
164 | potassium ion export (GO:0071435) | 2.39985900 |
165 | hexose biosynthetic process (GO:0019319) | 2.39783229 |
166 | adult heart development (GO:0007512) | 2.39308272 |
167 | striated muscle adaptation (GO:0014888) | 2.35681950 |
168 | negative regulation of potassium ion transmembrane transport (GO:1901380) | 2.35660733 |
169 | fructose metabolic process (GO:0006000) | 2.35311720 |
170 | negative regulation of calcium ion transmembrane transport (GO:1903170) | 2.33562172 |
171 | negative regulation of calcium ion transmembrane transporter activity (GO:1901020) | 2.33562172 |
172 | negative regulation of ryanodine-sensitive calcium-release channel activity (GO:0060315) | 2.32409551 |
173 | detection of calcium ion (GO:0005513) | 2.31800063 |
174 | positive regulation of receptor recycling (GO:0001921) | 2.31353415 |
175 | peptidyl-glutamic acid carboxylation (GO:0017187) | 2.29806404 |
176 | protein carboxylation (GO:0018214) | 2.29806404 |
177 | skeletal muscle adaptation (GO:0043501) | 2.26740937 |
178 | regulation of fibrinolysis (GO:0051917) | 2.26661241 |
179 | ventricular cardiac muscle cell action potential (GO:0086005) | 2.26069909 |
180 | erythrose 4-phosphate/phosphoenolpyruvate family amino acid catabolic process (GO:1902222) | 2.25807414 |
181 | L-phenylalanine catabolic process (GO:0006559) | 2.25807414 |
182 | glucan biosynthetic process (GO:0009250) | 2.25744357 |
183 | glycogen biosynthetic process (GO:0005978) | 2.25744357 |
184 | response to mercury ion (GO:0046689) | 2.25562888 |
185 | regulation of cardiac muscle contraction (GO:0055117) | 2.23544474 |
186 | ventricular cardiac muscle tissue morphogenesis (GO:0055010) | 2.22813190 |
187 | regulation of protein activation cascade (GO:2000257) | 2.22675836 |
188 | cellular potassium ion homeostasis (GO:0030007) | 2.22632989 |
189 | cellular response to epinephrine stimulus (GO:0071872) | 2.22226954 |
190 | cardiac cell development (GO:0055006) | 2.20989231 |
Rank | Gene Set | Z-score |
---|---|---|
1 | EZH2_22144423_ChIP-Seq_EOC_Human | 5.42634237 |
2 | E4F1_26484288_ChIP-Seq_MOUSE_EMBRYONIC_FIBROBLAST_Mouse | 4.54761897 |
3 | ESR1_17901129_ChIP-ChIP_LIVER_Mouse | 3.50251404 |
4 | NR4A2_19515692_ChIP-ChIP_MN9D_Mouse | 3.21478882 |
5 | ESRRB_18555785_ChIP-Seq_MESCs_Mouse | 2.90998261 |
6 | GBX2_23144817_ChIP-Seq_PC3_Human | 2.86463787 |
7 | CDKN2AIP_20523734_ChIP-Seq_CORTICAL_Neurons | 2.67596335 |
8 | TAL1_26923725_Chip-Seq_MACROPHAGESS_Mouse | 2.61616892 |
9 | ESR2_21235772_ChIP-Seq_MCF-7_Human | 2.47098827 |
10 | REST_21632747_ChIP-Seq_MESCs_Mouse | 2.46468800 |
11 | TCF21_23034159_ChIP-ChIP_E13_GONADS_Rat | 2.43385651 |
12 | RXR_22158963_ChIP-Seq_LIVER_Mouse | 2.36099288 |
13 | REST_18959480_ChIP-ChIP_MESCs_Mouse | 2.31823861 |
14 | NR1I2_20693526_ChIP-Seq_LIVER_Mouse | 2.28534612 |
15 | EP300_21415370_ChIP-Seq_HL-1_Mouse | 2.28160124 |
16 | MYCN_19997598_ChIP-ChIP_NEUROBLASTOMA_Human | 2.27337328 |
17 | * RARB_27405468_Chip-Seq_BRAIN_Mouse | 2.21796401 |
18 | FOXO1_23066095_ChIP-Seq_LIVER_Mouse | 2.19121043 |
19 | SUZ12_20075857_ChIP-Seq_MESCs_Mouse | 2.17968012 |
20 | ESR1_20079471_ChIP-ChIP_T-47D_Human | 2.16848066 |
21 | NOTCH1_17114293_ChIP-ChIP_T-ALL_Human | 2.16703167 |
22 | SUZ12_18692474_ChIP-Seq_MESCs_Mouse | 2.16570715 |
23 | SUZ12_18555785_ChIP-Seq_MESCs_Mouse | 2.14718563 |
24 | LXR_22158963_ChIP-Seq_LIVER_Mouse | 2.11647285 |
25 | TBX20_22080862_ChIP-Seq_HEART_Mouse | 2.07141122 |
26 | TBX20_22328084_ChIP-Seq_HEART_Mouse | 2.07141122 |
27 | CLOCK_20551151_ChIP-Seq_293T_Human | 1.95122707 |
28 | PPARA_22158963_ChIP-Seq_LIVER_Mouse | 1.91878974 |
29 | TAF7L_23326641_ChIP-Seq_C3H10T1-2_Mouse | 1.87878043 |
30 | MTF2_20144788_ChIP-Seq_MESCs_Mouse | 1.85681745 |
31 | JARID1A_20064375_ChIP-Seq_MESCs_Mouse | 1.84758537 |
32 | JARID2_20075857_ChIP-Seq_MESCs_Mouse | 1.84624589 |
33 | ETS1_20019798_ChIP-Seq_JURKAT_Human | 1.84232308 |
34 | EED_16625203_ChIP-ChIP_MESCs_Mouse | 1.83391984 |
35 | JARID2_20064375_ChIP-Seq_MESCs_Mouse | 1.77780511 |
36 | SUZ12_16625203_ChIP-ChIP_MESCs_Mouse | 1.75198673 |
37 | EZH2_18974828_ChIP-Seq_MESCs_Mouse | 1.72329294 |
38 | RNF2_18974828_ChIP-Seq_MESCs_Mouse | 1.72329294 |
39 | SIN3A_21632747_ChIP-Seq_MESCs_Mouse | 1.70250534 |
40 | THAP11_20581084_ChIP-Seq_MESCs_Mouse | 1.69934557 |
41 | SUZ12_18692474_ChIP-Seq_MEFs_Mouse | 1.66885991 |
42 | SMAD_19615063_ChIP-ChIP_OVARY_Human | 1.66091505 |
43 | TCF21_26020271_ChIP-Seq_SMOOTH_MUSCLE_Human | 1.63749692 |
44 | EZH2_27304074_Chip-Seq_ESCs_Mouse | 1.63068678 |
45 | ESR1_21235772_ChIP-Seq_MCF-7_Human | 1.62632156 |
46 | CTNNB1_20615089_ChIP-ChIP_FETAL_BRAIN_Human | 1.61882178 |
47 | SUZ12_18974828_ChIP-Seq_MESCs_Mouse | 1.60436984 |
48 | PPARD_23176727_ChIP-Seq_KERATINOCYTES_Mouse | 1.58569843 |
49 | ESR1_22446102_ChIP-Seq_UTERUS_Mouse | 1.56901655 |
50 | YY1_21170310_ChIP-Seq_MESCs_Mouse | 1.56284555 |
51 | EZH2_27294783_Chip-Seq_ESCs_Mouse | 1.55294211 |
52 | ERG_21242973_ChIP-ChIP_JURKAT_Human | 1.54871260 |
53 | TFAP2C_20629094_ChIP-Seq_MCF-7_Human | 1.51675030 |
54 | BP1_19119308_ChIP-ChIP_Hs578T_Human | 1.51362105 |
55 | PHC1_16625203_ChIP-ChIP_MESCs_Mouse | 1.48828145 |
56 | GATA2_21666600_ChIP-Seq_HMVEC_Human | 1.45896137 |
57 | TRIM28_21343339_ChIP-Seq_HEK293_Human | 1.45749594 |
58 | NFIB_24661679_ChIP-Seq_LUNG_Mouse | 1.44201837 |
59 | GATA2_26923725_Chip-Seq_HEMANGIOBLAST_Mouse | 1.44037050 |
60 | PDX1_19855005_ChIP-ChIP_MIN6_Mouse | 1.42213841 |
61 | PRDM16_22522345_ChIP-ChIP_PALATE_MESENCHYMAL_Mouse | 1.41561248 |
62 | * FOXA2_19822575_ChIP-Seq_HepG2_Human | 1.40895864 |
63 | HCFC1_20581084_ChIP-Seq_MESCs_Mouse | 1.40456027 |
64 | NUCKS1_24931609_ChIP-Seq_HEPATOCYTES_Mouse | 1.36169118 |
65 | TRP63_18441228_ChIP-ChIP_KERATINOCYTES_Mouse | 1.34632283 |
66 | Nerf2_26677805_Chip-Seq_MACROPHAGESS_Mouse | 1.34290091 |
67 | MEF2A_21415370_ChIP-Seq_HL-1_Mouse | 1.33194832 |
68 | IKZF1_21737484_ChIP-ChIP_HCT116_Human | 1.32666471 |
69 | * RUNX2_24764292_ChIP-Seq_MC3T3_Mouse | 1.31609481 |
70 | RUNX1_26923725_Chip-Seq_MACROPHAGESS_Mouse | 1.31490968 |
71 | * RCOR3_21632747_ChIP-Seq_MESCs_Mouse | 1.30933956 |
72 | ZNF263_19887448_ChIP-Seq_K562_Human | 1.29720170 |
73 | ZNF217_24962896_ChIP-Seq_MCF-7_Human | 1.28756652 |
74 | SUZ12_27294783_Chip-Seq_ESCs_Mouse | 1.28352161 |
75 | AR_21572438_ChIP-Seq_LNCaP_Human | 1.28032888 |
76 | KDM6A_18722178_ChIP-ChIP_U937_AND_SAOS2_Human | 1.27906364 |
77 | SIN3B_21632747_ChIP-Seq_MESCs_Mouse | 1.27749384 |
78 | NRF2_20460467_ChIP-Seq_MEFs_Mouse | 1.25145627 |
79 | NFE2L2_20460467_ChIP-Seq_MEFs_Mouse | 1.25145627 |
80 | PPARG_19300518_ChIP-PET_3T3-L1_Mouse | 1.23085790 |
81 | PBX_27287812_Chip-Seq_EMBYONIC-LIMB_Mouse | 1.22500295 |
82 | CREB1_15753290_ChIP-ChIP_HEK293T_Human | 1.22379594 |
83 | VDR_22108803_ChIP-Seq_LS180_Human | 1.20177514 |
84 | LXR_22292898_ChIP-Seq_THP-1_Human | 1.14642424 |
85 | STAT3_22323479_ChIP-Seq_MACROPHAGE_Mouse | 1.13542094 |
86 | WT1_20215353_ChIP-ChIP_NEPHRON_PROGENITOR_Mouse | 1.12769046 |
87 | SALL4_18804426_ChIP-ChIP_XEN_Mouse | 1.12665970 |
88 | TCF7L2_21901280_ChIP-Seq_H4IIE_Rat | 1.11665819 |
89 | CEBPB_21427703_ChIP-Seq_3T3-L1_Mouse | 1.11019458 |
90 | CJUN_26792858_Chip-Seq_BT549_Human | 1.09895136 |
91 | SMAD3_22036565_ChIP-Seq_ESCs_Mouse | 1.09101072 |
92 | ETS2_20176728_ChIP-ChIP_TROPHOBLAST_STEM_CELLS_Mouse | 1.08787475 |
93 | NACC1_18358816_ChIP-ChIP_MESCs_Mouse | 1.08770660 |
94 | SREBP1_19666523_ChIP-Seq_LIVER_Mouse | 1.06956700 |
95 | NR3C1_23031785_ChIP-Seq_PC12_Mouse | 1.06519131 |
96 | CRX_20693478_ChIP-Seq_ADULT_RETINA_Mouse | 1.06415449 |
97 | * NR0B1_18358816_ChIP-ChIP_MESCs_Mouse | 1.06332124 |
98 | SOX9_25088423_ChIP-ChIP_EMBRYONIC_GONADS_Mouse | 1.06049583 |
99 | TET1_21451524_ChIP-Seq_MESCs_Mouse | 1.05509066 |
100 | THRA_23701648_ChIP-Seq_CEREBELLUM_Mouse | 1.03721867 |
101 | NKX2-5_21415370_ChIP-Seq_HL-1_Mouse | 1.02118970 |
102 | TET1_21490601_ChIP-Seq_MESCs_Mouse | 1.01683883 |
103 | WT1_25993318_ChIP-Seq_PODOCYTE_Human | 1.01259317 |
104 | SOX9_24532713_ChIP-Seq_HFSC_Mouse | 1.00894335 |
105 | GATA4_21415370_ChIP-Seq_HL-1_Mouse | 0.98883424 |
106 | * RACK7_27058665_Chip-Seq_MCF-7_Human | 0.98016917 |
107 | BACH1_22875853_ChIP-PCR_HELA_AND_SCP4_Human | 0.97826087 |
108 | HOXC9_25013753_ChIP-Seq_NEUROBLASTOMA_BE2-C_Human | 0.97244423 |
109 | RARG_19884340_ChIP-ChIP_MEFs_Mouse | 0.96126662 |
110 | RNF2_27304074_Chip-Seq_ESCs_Mouse | 0.95902990 |
111 | PPAR_26484153_Chip-Seq_NCI-H1993_Human | 0.95698185 |
112 | REST_19997604_ChIP-ChIP_NEURONS_Mouse | 0.94484093 |
113 | EOMES_21245162_ChIP-Seq_HESCs_Human | 0.93544182 |
114 | SOX2_20726797_ChIP-Seq_SW620_Human | 0.91730121 |
115 | CTBP2_25329375_ChIP-Seq_LNCAP_Human | 0.91307559 |
116 | DNAJC2_21179169_ChIP-ChIP_NT2_Human | 0.91301062 |
117 | * EP300_20729851_ChIP-Seq_FORBRAIN_MIDBRAIN_LIMB_HEART_Mouse | 0.91282483 |
118 | TP53_23651856_ChIP-Seq_MEFs_Mouse | 0.89773014 |
119 | RCOR2_21632747_ChIP-Seq_MESCs_Mouse | 0.89751045 |
120 | PPARG_20176806_ChIP-Seq_3T3-L1_Mouse | 0.88699876 |
121 | CTNNB1_20460455_ChIP-Seq_HCT116_Human | 0.88584819 |
122 | CIITA_18437201_ChIP-ChIP_Raji_B_and_iDC_Human | 0.88119175 |
123 | FOXP2_21765815_ChIP-ChIP_NEURO2A_Mouse | 0.87898744 |
124 | P300_27058665_Chip-Seq_ZR-75-30cells_Human | 0.87031579 |
125 | AR_25329375_ChIP-Seq_VCAP_Human | 0.87026848 |
126 | CTCF_27219007_Chip-Seq_Bcells_Human | 0.86713700 |
127 | TAF15_26573619_Chip-Seq_HEK293_Human | 0.86648058 |
128 | SMAD2/3_21741376_ChIP-Seq_EPCs_Human | 0.86407204 |
129 | CEBPB_26923725_Chip-Seq_MESODERM_Mouse | 0.86142764 |
130 | SMC3_22415368_ChIP-Seq_MEFs_Mouse | 0.85039653 |
131 | ERA_27197147_Chip-Seq_ENDOMETRIOID-ADENOCARCINOMA_Human | 0.84088709 |
132 | SMARCA4_20176728_ChIP-ChIP_TSCs_Mouse | 0.84070851 |
133 | SCL_21571218_ChIP-Seq_MEGAKARYOCYTES_Human | 0.83569685 |
134 | SMC4_20622854_ChIP-Seq_HELA_Human | 0.82963134 |
135 | EZH2_23942234_ChIP-Seq_MYOBLASTS_AND_MYOTUBES_Mouse | 0.82909830 |
136 | CTCF_18555785_ChIP-Seq_MESCs_Mouse | 0.82178729 |
137 | SOX2_27498859_Chip-Seq_STOMACH_Mouse | 0.82099423 |
138 | IRF1_19129219_ChIP-ChIP_H3396_Human | 0.82049215 |
139 | WT1_19549856_ChIP-ChIP_CCG9911_Human | 0.81907069 |
140 | ERA_21632823_ChIP-Seq_H3396_Human | 0.81885379 |
141 | SRF_21415370_ChIP-Seq_HL-1_Mouse | 0.81850324 |
142 | KDM2B_26808549_Chip-Seq_SUP-B15_Human | 0.81678537 |
143 | CDX2_19796622_ChIP-Seq_MESCs_Mouse | 0.81663500 |
144 | GATA1_19941827_ChIP-Seq_MEL_Mouse | 0.81624232 |
145 | MYCN_27167114_Chip-Seq_NEUROBLASTOMA_Human | 0.80735297 |
146 | SMAD4_21799915_ChIP-Seq_A2780_Human | 0.80395726 |
147 | BMI1_23680149_ChIP-Seq_NPCS_Mouse | 0.79572688 |
148 | SMARCA4_23332759_ChIP-Seq_OLIGODENDROCYTES_Mouse | 0.79436762 |
149 | CTBP1_25329375_ChIP-Seq_LNCAP_Human | 0.78216199 |
150 | * BCL3_23251550_ChIP-Seq_MUSCLE_Mouse | 0.77702137 |
151 | * EGR1_20690147_ChIP-Seq_ERYTHROLEUKEMIA_Human | 0.77635413 |
152 | NR1H3_23393188_ChIP-Seq_ATHEROSCLEROTIC-FOAM_Human | 0.77632441 |
153 | JUN_26020271_ChIP-Seq_SMOOTH_MUSCLE_Human | 0.77202955 |
154 | ZFP281_18757296_ChIP-ChIP_E14_Mouse | 0.76534090 |
155 | MEIS1_26923725_Chip-Seq_HEMOGENIC-ENDOTHELIUM_Mouse | 0.76417086 |
156 | SMC1_22415368_ChIP-Seq_MEFs_Mouse | 0.74554575 |
157 | FOXH1_21741376_ChIP-Seq_ESCs_Human | 0.73708403 |
158 | * HNF4A_19822575_ChIP-Seq_HepG2_Human | 0.73700238 |
159 | TAF2_19829295_ChIP-Seq_ESCs_Human | 0.73411660 |
160 | POU5F1_18700969_ChIP-ChIP_MESCs_Mouse | 0.73354473 |
161 | DROSHA_22980978_ChIP-Seq_HELA_Human | 0.72198594 |
162 | KDM2B_26808549_Chip-Seq_K562_Human | 0.72077380 |
163 | * TRIM28_19339689_ChIP-ChIP_MESCs_Mouse | 0.71451473 |
164 | KLF4_19829295_ChIP-Seq_ESCs_Human | 0.71093394 |
165 | * SRY_25088423_ChIP-ChIP_EMBRYONIC_GONADS_Mouse | 0.70644578 |
166 | RBPJ_21746931_ChIP-Seq_IB4_Human | 0.69140539 |
167 | SMAD3_21741376_ChIP-Seq_HESCs_Human | 0.69094729 |
Rank | Gene Set | Z-score |
---|---|---|
1 | MP0001968_abnormal_touch/_nociception | 4.19431833 |
2 | MP0003122_maternal_imprinting | 3.82661567 |
3 | MP0004859_abnormal_synaptic_plasticity | 3.66404588 |
4 | MP0003123_paternal_imprinting | 3.46377732 |
5 | MP0003880_abnormal_central_pattern | 3.42511856 |
6 | MP0008260_abnormal_autophagy | 3.31383152 |
7 | MP0000751_myopathy | 2.79008157 |
8 | MP0004270_analgesia | 2.70091173 |
9 | MP0003635_abnormal_synaptic_transmissio | 2.69342995 |
10 | MP0006276_abnormal_autonomic_nervous | 2.66974007 |
11 | MP0004087_abnormal_muscle_fiber | 2.59387927 |
12 | MP0002064_seizures | 2.56867736 |
13 | MP0004510_myositis | 2.49591736 |
14 | MP0009745_abnormal_behavioral_response | 2.36519565 |
15 | MP0001986_abnormal_taste_sensitivity | 2.32696714 |
16 | MP0002106_abnormal_muscle_physiology | 2.31303053 |
17 | MP0002736_abnormal_nociception_after | 2.30388730 |
18 | MP0009046_muscle_twitch | 2.29968298 |
19 | MP0009780_abnormal_chondrocyte_physiolo | 2.24665947 |
20 | MP0002139_abnormal_hepatobiliary_system | 2.23723848 |
21 | MP0002272_abnormal_nervous_system | 2.23316311 |
22 | MP0002735_abnormal_chemical_nociception | 2.20282363 |
23 | MP0002067_abnormal_sensory_capabilities | 2.13848917 |
24 | MP0002734_abnormal_mechanical_nocicepti | 2.12811026 |
25 | MP0000759_abnormal_skeletal_muscle | 2.10224614 |
26 | MP0005423_abnormal_somatic_nervous | 2.08795566 |
27 | MP0001188_hyperpigmentation | 2.06991063 |
28 | MP0002063_abnormal_learning/memory/cond | 1.92985886 |
29 | MP0002822_catalepsy | 1.91735038 |
30 | MP0005369_muscle_phenotype | 1.90252770 |
31 | MP0003121_genomic_imprinting | 1.88918885 |
32 | MP0000750_abnormal_muscle_regeneration | 1.88044146 |
33 | MP0002837_dystrophic_cardiac_calcinosis | 1.87441683 |
34 | MP0003646_muscle_fatigue | 1.85874043 |
35 | MP0001970_abnormal_pain_threshold | 1.84118405 |
36 | MP0004142_abnormal_muscle_tone | 1.79078849 |
37 | MP0002733_abnormal_thermal_nociception | 1.76275085 |
38 | MP0006138_congestive_heart_failure | 1.73049096 |
39 | MP0005645_abnormal_hypothalamus_physiol | 1.71207395 |
40 | MP0002572_abnormal_emotion/affect_behav | 1.70588229 |
41 | MP0001905_abnormal_dopamine_level | 1.61779705 |
42 | MP0001661_extended_life_span | 1.61652306 |
43 | MP0000749_muscle_degeneration | 1.58920553 |
44 | MP0005167_abnormal_blood-brain_barrier | 1.54958573 |
45 | MP0010630_abnormal_cardiac_muscle | 1.54714679 |
46 | MP0001440_abnormal_grooming_behavior | 1.54457288 |
47 | MP0003950_abnormal_plasma_membrane | 1.53928823 |
48 | MP0005165_increased_susceptibility_to | 1.52894947 |
49 | MP0005058_abnormal_lysosome_morphology | 1.52217061 |
50 | MP0001501_abnormal_sleep_pattern | 1.45898619 |
51 | MP0005385_cardiovascular_system_phenoty | 1.42804499 |
52 | MP0001544_abnormal_cardiovascular_syste | 1.42804499 |
53 | MP0004036_abnormal_muscle_relaxation | 1.42654880 |
54 | MP0005409_darkened_coat_color | 1.40780933 |
55 | MP0000747_muscle_weakness | 1.40623318 |
56 | MP0004084_abnormal_cardiac_muscle | 1.36486396 |
57 | MP0004130_abnormal_muscle_cell | 1.36224265 |
58 | MP0005365_abnormal_bile_salt | 1.36091223 |
59 | MP0008775_abnormal_heart_ventricle | 1.34260888 |
60 | MP0001727_abnormal_embryo_implantation | 1.30244011 |
61 | MP0002909_abnormal_adrenal_gland | 1.29536812 |
62 | MP0005084_abnormal_gallbladder_morpholo | 1.27609431 |
63 | MP0004924_abnormal_behavior | 1.27582019 |
64 | MP0005386_behavior/neurological_phenoty | 1.27582019 |
65 | MP0000733_abnormal_muscle_development | 1.27439388 |
66 | MP0002876_abnormal_thyroid_physiology | 1.27097848 |
67 | MP0000003_abnormal_adipose_tissue | 1.27010477 |
68 | MP0000013_abnormal_adipose_tissue | 1.25720617 |
69 | MP0002638_abnormal_pupillary_reflex | 1.25253911 |
70 | MP0003172_abnormal_lysosome_physiology | 1.21755058 |
71 | MP0005670_abnormal_white_adipose | 1.21322770 |
72 | MP0001486_abnormal_startle_reflex | 1.20105616 |
73 | MP0004811_abnormal_neuron_physiology | 1.18018566 |
74 | MP0002971_abnormal_brown_adipose | 1.17562631 |
75 | MP0003191_abnormal_cellular_cholesterol | 1.17452197 |
76 | MP0003566_abnormal_cell_adhesion | 1.17189640 |
77 | MP0003690_abnormal_glial_cell | 1.16962452 |
78 | MP0002751_abnormal_autonomic_nervous | 1.16684979 |
79 | MP0005623_abnormal_meninges_morphology | 1.15683052 |
80 | MP0003075_altered_response_to | 1.12929630 |
81 | MP0008438_abnormal_cutaneous_collagen | 1.12890262 |
82 | MP0003137_abnormal_impulse_conducting | 1.10969300 |
83 | MP0000604_amyloidosis | 1.09980764 |
84 | MP0002127_abnormal_cardiovascular_syste | 1.09638666 |
85 | MP0002066_abnormal_motor_capabilities/c | 1.08890061 |
86 | MP0000343_altered_response_to | 1.07974981 |
87 | MP0003828_pulmonary_edema | 1.07269619 |
88 | MP0009379_abnormal_foot_pigmentation | 1.07102852 |
89 | MP0002184_abnormal_innervation | 1.06927873 |
90 | MP0003705_abnormal_hypodermis_morpholog | 1.06372020 |
91 | MP0004484_altered_response_of | 1.06182389 |
92 | MP0010329_abnormal_lipoprotein_level | 1.05801887 |
93 | MP0009840_abnormal_foam_cell | 1.02512663 |
94 | MP0003879_abnormal_hair_cell | 1.00985526 |
95 | MP0003633_abnormal_nervous_system | 0.99092458 |
96 | MP0002108_abnormal_muscle_morphology | 0.98575418 |
97 | MP0001984_abnormal_olfaction | 0.98574616 |
98 | MP0003329_amyloid_beta_deposits | 0.97290668 |
99 | MP0002557_abnormal_social/conspecific_i | 0.96545104 |
100 | MP0005375_adipose_tissue_phenotype | 0.96384642 |
101 | MP0002877_abnormal_melanocyte_morpholog | 0.94840469 |
102 | MP0008569_lethality_at_weaning | 0.94285022 |
103 | MP0005330_cardiomyopathy | 0.93098591 |
104 | MP0002332_abnormal_exercise_endurance | 0.92543044 |
105 | MP0003136_yellow_coat_color | 0.91126854 |
106 | MP0004233_abnormal_muscle_weight | 0.90355190 |
107 | MP0004145_abnormal_muscle_electrophysio | 0.90238225 |
108 | MP0001502_abnormal_circadian_rhythm | 0.90146594 |
109 | MP0005448_abnormal_energy_balance | 0.89005457 |
110 | MP0002269_muscular_atrophy | 0.88981175 |
111 | MP0002229_neurodegeneration | 0.88881475 |
112 | MP0002896_abnormal_bone_mineralization | 0.88160798 |
113 | MP0004215_abnormal_myocardial_fiber | 0.87411555 |
114 | MP0010368_abnormal_lymphatic_system | 0.85533929 |
115 | MP0002882_abnormal_neuron_morphology | 0.85331224 |
116 | MP0005535_abnormal_body_temperature | 0.84612492 |
117 | MP0005085_abnormal_gallbladder_physiolo | 0.84565808 |
118 | MP0000230_abnormal_systemic_arterial | 0.84440598 |
119 | MP0003279_aneurysm | 0.84154462 |
120 | MP0006035_abnormal_mitochondrial_morpho | 0.83894400 |
121 | MP0002118_abnormal_lipid_homeostasis | 0.83753016 |
122 | MP0005595_abnormal_vascular_smooth | 0.82909095 |
123 | MP0006292_abnormal_olfactory_placode | 0.81372458 |
124 | MP0009333_abnormal_splenocyte_physiolog | 0.80385093 |
125 | MP0003091_abnormal_cell_migration | 0.79863242 |
126 | MP0005332_abnormal_amino_acid | 0.79836890 |
127 | MP0005408_hypopigmentation | 0.79600077 |
128 | MP0000920_abnormal_myelination | 0.78469721 |
129 | MP0003631_nervous_system_phenotype | 0.76263189 |
130 | MP0003195_calcinosis | 0.76249099 |
131 | MP0005666_abnormal_adipose_tissue | 0.74628855 |
132 | MP0005257_abnormal_intraocular_pressure | 0.73963352 |
133 | MP0006036_abnormal_mitochondrial_physio | 0.73901104 |
134 | MP0002069_abnormal_eating/drinking_beha | 0.73512909 |
135 | MP0001958_emphysema | 0.73408371 |
136 | MP0004272_abnormal_basement_membrane | 0.73241266 |
137 | MP0008875_abnormal_xenobiotic_pharmacok | 0.70964052 |
138 | MP0003868_abnormal_feces_composition | 0.70319971 |
139 | MP0000639_abnormal_adrenal_gland | 0.70117841 |
140 | MP0005166_decreased_susceptibility_to | 0.69922130 |
141 | MP0003634_abnormal_glial_cell | 0.69562416 |
142 | MP0002972_abnormal_cardiac_muscle | 0.69344656 |
143 | MP0005620_abnormal_muscle_contractility | 0.68843088 |
144 | MP0005584_abnormal_enzyme/coenzyme_acti | 0.68727130 |
145 | MP0003045_fibrosis | 0.68310799 |
146 | MP0003806_abnormal_nucleotide_metabolis | 0.68285148 |
147 | MP0000778_abnormal_nervous_system | 0.67639228 |
148 | MP0000767_abnormal_smooth_muscle | 0.67538935 |
149 | MP0004858_abnormal_nervous_system | 0.67505483 |
150 | MP0001542_abnormal_bone_strength | 0.67331115 |
151 | MP0008874_decreased_physiological_sensi | 0.67212732 |
152 | MP0001756_abnormal_urination | 0.65294133 |
153 | MP0005266_abnormal_metabolism | 0.65279168 |
154 | MP0004085_abnormal_heartbeat | 0.64992566 |
155 | MP0010234_abnormal_vibrissa_follicle | 0.64983031 |
156 | MP0002295_abnormal_pulmonary_circulatio | 0.64966294 |
157 | MP0005248_abnormal_Harderian_gland | 0.64509702 |
158 | MP0005451_abnormal_body_composition | 0.64478467 |
159 | MP0009672_abnormal_birth_weight | 0.63984154 |
160 | MP0005187_abnormal_penis_morphology | 0.63663766 |
161 | MP0002128_abnormal_blood_circulation | 0.63563334 |
162 | MP0000372_irregular_coat_pigmentation | 0.62793568 |
163 | MP0005171_absent_coat_pigmentation | 0.61010892 |
164 | MP0001849_ear_inflammation | 0.60905096 |
Rank | Gene Set | Z-score |
---|---|---|
1 | Focal motor seizures (HP:0011153) | 9.59205518 |
2 | Muscle fiber inclusion bodies (HP:0100299) | 6.80374752 |
3 | Nemaline bodies (HP:0003798) | 6.74457755 |
4 | Atonic seizures (HP:0010819) | 6.69907911 |
5 | Muscle fiber cytoplasmatic inclusion bodies (HP:0100303) | 6.65669383 |
6 | Type 1 muscle fiber predominance (HP:0003803) | 5.68255311 |
7 | Failure to thrive in infancy (HP:0001531) | 5.00839430 |
8 | Polyphagia (HP:0002591) | 5.00529475 |
9 | Myokymia (HP:0002411) | 4.82727280 |
10 | Febrile seizures (HP:0002373) | 4.77867505 |
11 | Hyporeflexia of lower limbs (HP:0002600) | 4.66613077 |
12 | Exercise-induced muscle cramps (HP:0003710) | 4.62208464 |
13 | Oligomenorrhea (HP:0000876) | 4.58295391 |
14 | Asymmetric septal hypertrophy (HP:0001670) | 4.47207129 |
15 | Hypoglycemic seizures (HP:0002173) | 4.37425180 |
16 | Absence seizures (HP:0002121) | 4.34532560 |
17 | Focal seizures (HP:0007359) | 4.29332200 |
18 | EMG: myopathic abnormalities (HP:0003458) | 4.27312442 |
19 | Abnormal hair whorl (HP:0010721) | 4.26306304 |
20 | Hemiplegia (HP:0002301) | 4.07060708 |
21 | Muscle hypertrophy of the lower extremities (HP:0008968) | 4.03296702 |
22 | Dialeptic seizures (HP:0011146) | 3.91105698 |
23 | Distal lower limb muscle weakness (HP:0009053) | 3.87958565 |
24 | Abnormality of the calf musculature (HP:0001430) | 3.81339824 |
25 | Calf muscle hypertrophy (HP:0008981) | 3.80383620 |
26 | Abnormal eating behavior (HP:0100738) | 3.62684707 |
27 | Double outlet right ventricle (HP:0001719) | 3.62168431 |
28 | Congenital malformation of the right heart (HP:0011723) | 3.62168431 |
29 | Abnormality of the labia minora (HP:0012880) | 3.57882855 |
30 | Centrally nucleated skeletal muscle fibers (HP:0003687) | 3.54206685 |
31 | Myoglobinuria (HP:0002913) | 3.49601896 |
32 | Rhabdomyolysis (HP:0003201) | 3.45071579 |
33 | Abnormality of skeletal muscle fiber size (HP:0012084) | 3.44645040 |
34 | Ventricular tachycardia (HP:0004756) | 3.41778758 |
35 | Subaortic stenosis (HP:0001682) | 3.38945164 |
36 | Abnormality of the left ventricular outflow tract (HP:0011103) | 3.38945164 |
37 | Distal arthrogryposis (HP:0005684) | 3.32115709 |
38 | Epileptic encephalopathy (HP:0200134) | 3.30495894 |
39 | Neck muscle weakness (HP:0000467) | 3.28743265 |
40 | Increased connective tissue (HP:0009025) | 3.26761384 |
41 | Myopathic facies (HP:0002058) | 3.22682669 |
42 | Status epilepticus (HP:0002133) | 3.22550563 |
43 | Increased variability in muscle fiber diameter (HP:0003557) | 3.21758754 |
44 | Ulnar deviation of the wrist (HP:0003049) | 3.19265657 |
45 | Cortical visual impairment (HP:0100704) | 3.18826365 |
46 | Generalized tonic-clonic seizures (HP:0002069) | 3.12469612 |
47 | Sleep apnea (HP:0010535) | 3.09369874 |
48 | Round ear (HP:0100830) | 3.06231141 |
49 | Heart block (HP:0012722) | 3.05189773 |
50 | Abnormal atrioventricular conduction (HP:0005150) | 3.04571914 |
51 | Difficulty running (HP:0009046) | 2.95873765 |
52 | Poor suck (HP:0002033) | 2.92030042 |
53 | Retinal dysplasia (HP:0007973) | 2.88261203 |
54 | Distal lower limb amyotrophy (HP:0008944) | 2.85722882 |
55 | Rimmed vacuoles (HP:0003805) | 2.85078705 |
56 | Hemiparesis (HP:0001269) | 2.84168039 |
57 | Frequent falls (HP:0002359) | 2.82051570 |
58 | Symptomatic seizures (HP:0011145) | 2.77314300 |
59 | Postnatal microcephaly (HP:0005484) | 2.75493982 |
60 | Dilated cardiomyopathy (HP:0001644) | 2.75105335 |
61 | Lipoatrophy (HP:0100578) | 2.71092303 |
62 | Type II lissencephaly (HP:0007260) | 2.70141884 |
63 | Cerebral hypomyelination (HP:0006808) | 2.68664191 |
64 | Abnormality of pain sensation (HP:0010832) | 2.67974380 |
65 | Impaired pain sensation (HP:0007328) | 2.67974380 |
66 | Mildly elevated creatine phosphokinase (HP:0008180) | 2.65209675 |
67 | Generalized myoclonic seizures (HP:0002123) | 2.64997924 |
68 | Ventricular arrhythmia (HP:0004308) | 2.61479663 |
69 | Atrial fibrillation (HP:0005110) | 2.54463219 |
70 | Muscle fiber splitting (HP:0003555) | 2.53356967 |
71 | EMG: neuropathic changes (HP:0003445) | 2.49820605 |
72 | Atrioventricular block (HP:0001678) | 2.49298798 |
73 | Hyperventilation (HP:0002883) | 2.47145416 |
74 | Generalized hypotonia (HP:0001290) | 2.41813488 |
75 | Hypoventilation (HP:0002791) | 2.38203210 |
76 | Rhabdomyosarcoma (HP:0002859) | 2.37498943 |
77 | Delusions (HP:0000746) | 2.34998560 |
78 | Syncope (HP:0001279) | 2.34895721 |
79 | Deep venous thrombosis (HP:0002625) | 2.34793649 |
80 | Spinal rigidity (HP:0003306) | 2.33521709 |
81 | Muscle stiffness (HP:0003552) | 2.33182325 |
82 | Primary atrial arrhythmia (HP:0001692) | 2.30542603 |
83 | Lower limb amyotrophy (HP:0007210) | 2.30453504 |
84 | Action tremor (HP:0002345) | 2.30005102 |
85 | Pheochromocytoma (HP:0002666) | 2.28113808 |
86 | Patent foramen ovale (HP:0001655) | 2.23871486 |
87 | Generalized muscle weakness (HP:0003324) | 2.23836200 |
88 | Decreased muscle mass (HP:0003199) | 2.23098731 |
89 | Supraventricular tachycardia (HP:0004755) | 2.22927937 |
90 | Scapular winging (HP:0003691) | 2.22134788 |
91 | Supraventricular arrhythmia (HP:0005115) | 2.21603946 |
92 | Areflexia of lower limbs (HP:0002522) | 2.21172391 |
93 | Complement deficiency (HP:0004431) | 2.20612599 |
94 | Right ventricular cardiomyopathy (HP:0011663) | 2.20196513 |
95 | Methylmalonic aciduria (HP:0012120) | 2.18781077 |
96 | Abnormal umbilical cord blood vessels (HP:0011403) | 2.14807927 |
97 | Single umbilical artery (HP:0001195) | 2.14807927 |
98 | Abnormality of the fetal cardiovascular system (HP:0010948) | 2.14807927 |
99 | Hypercortisolism (HP:0001578) | 2.14796578 |
100 | Abnormality of the foot musculature (HP:0001436) | 2.12261910 |
101 | Esotropia (HP:0000565) | 2.10773703 |
102 | Bulbar palsy (HP:0001283) | 2.10436366 |
103 | Ventricular fibrillation (HP:0001663) | 2.08879370 |
104 | Foot dorsiflexor weakness (HP:0009027) | 2.08538933 |
105 | Unsteady gait (HP:0002317) | 2.06720948 |
106 | Growth hormone excess (HP:0000845) | 2.06402629 |
107 | Neuroendocrine neoplasm (HP:0100634) | 2.04439550 |
108 | Truncus arteriosus (HP:0001660) | 2.04190326 |
109 | Mitral stenosis (HP:0001718) | 2.02925701 |
110 | Abnormality of glycolysis (HP:0004366) | 2.02650220 |
111 | Increased serum pyruvate (HP:0003542) | 2.02650220 |
112 | Supranuclear gaze palsy (HP:0000605) | 2.01949185 |
113 | Limb-girdle muscle atrophy (HP:0003797) | 1.99919261 |
114 | Calcaneovalgus deformity (HP:0001848) | 1.98664329 |
115 | Myotonia (HP:0002486) | 1.98336846 |
116 | Neurofibrillary tangles (HP:0002185) | 1.96938287 |
117 | Hip dysplasia (HP:0001385) | 1.95788946 |
118 | Gowers sign (HP:0003391) | 1.95198797 |
119 | Hypoalphalipoproteinemia (HP:0003233) | 1.94394199 |
120 | Systemic lupus erythematosus (HP:0002725) | 1.93241050 |
121 | Abnormality of the Achilles tendon (HP:0005109) | 1.92853012 |
122 | Spastic paraparesis (HP:0002313) | 1.91691521 |
123 | Bundle branch block (HP:0011710) | 1.90774385 |
124 | Narrow nasal bridge (HP:0000446) | 1.90630199 |
125 | Absent phalangeal crease (HP:0006109) | 1.90579803 |
126 | Difficulty climbing stairs (HP:0003551) | 1.90128311 |
127 | Abnormality of aromatic amino acid family metabolism (HP:0004338) | 1.89786012 |
128 | Urinary glycosaminoglycan excretion (HP:0003541) | 1.89598419 |
129 | Mucopolysacchariduria (HP:0008155) | 1.89598419 |
130 | Progressive cerebellar ataxia (HP:0002073) | 1.89554785 |
131 | Diaphragmatic weakness (HP:0009113) | 1.88378571 |
132 | Acute necrotizing encephalopathy (HP:0006965) | 1.88085773 |
133 | Abnormality of the aortic arch (HP:0012303) | 1.87766194 |
134 | Anomalous pulmonary venous return (HP:0010772) | 1.87744084 |
135 | Vascular calcification (HP:0004934) | 1.87036431 |
136 | Abnormality of polysaccharide metabolism (HP:0011012) | 1.85853220 |
137 | Abnormality of glycosaminoglycan metabolism (HP:0004371) | 1.85853220 |
138 | Abnormality of mucopolysaccharide metabolism (HP:0011020) | 1.85853220 |
139 | Skin nodule (HP:0200036) | 1.84484034 |
140 | Ragged-red muscle fibers (HP:0003200) | 1.84387747 |
141 | Nasal speech (HP:0001611) | 1.83022438 |
142 | Cardiovascular calcification (HP:0011915) | 1.82724416 |
143 | Cerebral inclusion bodies (HP:0100314) | 1.81519168 |
144 | Xanthomatosis (HP:0000991) | 1.81477030 |
145 | Hyperglycinemia (HP:0002154) | 1.80825591 |
146 | Abnormality of the umbilical cord (HP:0010881) | 1.80733159 |
147 | Joint hemorrhage (HP:0005261) | 1.79355222 |
148 | Exercise-induced myalgia (HP:0003738) | 1.78934304 |
149 | Progressive external ophthalmoplegia (HP:0000590) | 1.78355540 |
150 | Dysostosis multiplex (HP:0000943) | 1.78027361 |
151 | Abnormality of complement system (HP:0005339) | 1.77890934 |
152 | Abnormality of liposaccharide metabolism (HP:0010968) | 1.76426354 |
153 | Abnormality of glycosphingolipid metabolism (HP:0004343) | 1.76426354 |
154 | Abnormality of glycolipid metabolism (HP:0010969) | 1.76426354 |
155 | Scanning speech (HP:0002168) | 1.75757007 |
156 | Achilles tendon contracture (HP:0001771) | 1.74691886 |
157 | Abnormality of magnesium homeostasis (HP:0004921) | 1.74349126 |
158 | Deformed tarsal bones (HP:0008119) | 1.72633338 |
159 | Visual hallucinations (HP:0002367) | 1.71415827 |
160 | Cerebral aneurysm (HP:0004944) | 1.71222549 |
161 | Protrusio acetabuli (HP:0003179) | 1.70405302 |
162 | Muscular dystrophy (HP:0003560) | 1.70349038 |
163 | Palpitations (HP:0001962) | 1.69944536 |
164 | Dysmetria (HP:0001310) | 1.69632459 |
165 | Abnormality of the pulmonary veins (HP:0011718) | 1.69286845 |
166 | Ankle clonus (HP:0011448) | 1.68842335 |
167 | Abnormality of the anterior horn cell (HP:0006802) | 1.68375857 |
168 | Degeneration of anterior horn cells (HP:0002398) | 1.68375857 |
169 | Hepatocellular necrosis (HP:0001404) | 1.68137604 |
170 | Depression (HP:0000716) | 1.66095289 |
171 | Abnormal mitochondria in muscle tissue (HP:0008316) | 1.65710663 |
172 | Emotional lability (HP:0000712) | 1.65507811 |
173 | Abnormality of alanine metabolism (HP:0010916) | 1.65355524 |
174 | Hyperalaninemia (HP:0003348) | 1.65355524 |
175 | Abnormality of pyruvate family amino acid metabolism (HP:0010915) | 1.65355524 |
176 | Rapidly progressive (HP:0003678) | 1.64795050 |
177 | Testicular atrophy (HP:0000029) | 1.64778580 |
178 | Vertebral compression fractures (HP:0002953) | 1.62731070 |
179 | Malignant hyperthermia (HP:0002047) | 1.61351951 |
180 | Axonal loss (HP:0003447) | 1.60389809 |
181 | Psychosis (HP:0000709) | 1.60155515 |
182 | Steppage gait (HP:0003376) | 1.58578087 |
183 | Sudden death (HP:0001699) | 1.58074218 |
184 | Abnormal EKG (HP:0003115) | 1.57789352 |
185 | Methylmalonic acidemia (HP:0002912) | 1.57552961 |
186 | Broad distal phalanx of finger (HP:0009836) | 1.56506168 |
187 | Abnormal pupillary function (HP:0007686) | 1.53845781 |
188 | Progressive muscle weakness (HP:0003323) | 1.51087251 |
189 | Progressive neurologic deterioration (HP:0002344) | 1.50657020 |
Rank | Gene Set | Z-score |
---|---|---|
1 | OBSCN | 6.22779520 |
2 | TTN | 4.94421070 |
3 | NLK | 4.73646434 |
4 | CASK | 4.42409573 |
5 | ARAF | 3.75830409 |
6 | SGK2 | 3.18791195 |
7 | SGK494 | 2.85794618 |
8 | SGK223 | 2.85794618 |
9 | MAP3K9 | 2.63097791 |
10 | NME2 | 2.56290581 |
11 | PHKG1 | 2.28705115 |
12 | PHKG2 | 2.28705115 |
13 | AKT3 | 2.23457816 |
14 | RIPK1 | 2.22827018 |
15 | CSNK1G1 | 2.21807860 |
16 | MAP2K7 | 2.17745082 |
17 | SGK3 | 2.14207374 |
18 | DMPK | 2.03329694 |
19 | MAP3K12 | 2.02237585 |
20 | NTRK3 | 2.01429908 |
21 | BRAF | 1.99868014 |
22 | LIMK1 | 1.96372709 |
23 | CCNB1 | 1.93337184 |
24 | CDK19 | 1.84599710 |
25 | DYRK1A | 1.63281961 |
26 | LMTK2 | 1.62136152 |
27 | DAPK2 | 1.60807765 |
28 | MAP3K4 | 1.60712546 |
29 | ICK | 1.59662722 |
30 | CAMKK2 | 1.55408320 |
31 | BUB1 | 1.51562825 |
32 | IRAK3 | 1.48124591 |
33 | MAPKAPK3 | 1.45262082 |
34 | KSR2 | 1.44768061 |
35 | PIK3CG | 1.43620258 |
36 | PRPF4B | 1.41093409 |
37 | EPHA4 | 1.38812777 |
38 | MAP2K3 | 1.32987957 |
39 | PINK1 | 1.30514872 |
40 | MUSK | 1.30365586 |
41 | TGFBR2 | 1.28444552 |
42 | BCKDK | 1.28330458 |
43 | MARK1 | 1.26293134 |
44 | MINK1 | 1.23520091 |
45 | TRPM7 | 1.23213984 |
46 | NEK9 | 1.23199718 |
47 | NTRK1 | 1.22942375 |
48 | PLK2 | 1.20925844 |
49 | MAP2K4 | 1.16354692 |
50 | PDK3 | 1.15486595 |
51 | PDK4 | 1.15486595 |
52 | PDK2 | 1.13867923 |
53 | TESK1 | 1.12055487 |
54 | MAP3K1 | 1.11700219 |
55 | NME1 | 1.11194843 |
56 | TRIB3 | 1.09268145 |
57 | TAOK1 | 1.09088948 |
58 | DDR2 | 1.07085718 |
59 | PDGFRA | 1.02734947 |
60 | PAK6 | 1.00389967 |
61 | OXSR1 | 0.99867091 |
62 | CAMK2D | 0.99048536 |
63 | MAP3K3 | 0.97509011 |
64 | LATS2 | 0.95547186 |
65 | PIK3CA | 0.94836074 |
66 | EPHB1 | 0.92329352 |
67 | PRKAA2 | 0.92166726 |
68 | PRKD3 | 0.90555118 |
69 | MAP3K11 | 0.89415431 |
70 | MAP3K7 | 0.85368855 |
71 | PAK1 | 0.83742098 |
72 | GRK5 | 0.82321280 |
73 | ABL2 | 0.81253172 |
74 | PDPK1 | 0.80481557 |
75 | CDK4 | 0.79708029 |
76 | FER | 0.79481251 |
77 | PTK2 | 0.79429804 |
78 | CAMKK1 | 0.79294503 |
79 | DAPK1 | 0.77184041 |
80 | EPHA3 | 0.76971506 |
81 | EEF2K | 0.75527390 |
82 | MAP3K2 | 0.75306967 |
83 | PRKCG | 0.74879417 |
84 | BRSK2 | 0.74025152 |
85 | ROCK1 | 0.73797828 |
86 | NTRK2 | 0.71320719 |
87 | PRKD1 | 0.71212317 |
88 | MYLK | 0.70585786 |
89 | CDC42BPA | 0.69597623 |
90 | GSK3A | 0.69579036 |
91 | PRKAA1 | 0.69312954 |
92 | ROCK2 | 0.68474540 |
93 | TIE1 | 0.67129256 |
94 | CDK5 | 0.66688462 |
95 | AKT2 | 0.66508833 |
96 | MET | 0.65968325 |
97 | MKNK2 | 0.65026785 |
98 | DYRK1B | 0.64789663 |
99 | ERN1 | 0.63559843 |
100 | MAP2K6 | 0.62853694 |
101 | MAP3K13 | 0.62343977 |
102 | FGFR3 | 0.62219198 |
103 | FGFR4 | 0.61074043 |
104 | DAPK3 | 0.61035759 |
105 | STK38 | 0.60043618 |
106 | BRSK1 | 0.59443517 |
107 | CAMK4 | 0.59245655 |
108 | PAK3 | 0.58970971 |
109 | MAP2K1 | 0.57714506 |
110 | CDK14 | 0.57310793 |
111 | MAPK12 | 0.55941669 |
112 | PAK2 | 0.53992578 |
113 | CAMK2G | 0.53961333 |
114 | MST1R | 0.53936851 |
115 | AURKA | 0.52881699 |
116 | MAP3K6 | 0.52748959 |
117 | CAMK2A | 0.52694047 |
118 | PDK1 | 0.51303739 |
119 | SIK1 | 0.51268115 |
120 | ERBB3 | 0.51112423 |
121 | GRK7 | 0.50958418 |
122 | MAPK7 | 0.48948304 |
123 | RPS6KA2 | 0.47886646 |
124 | TSSK6 | 0.47198477 |
125 | KSR1 | 0.45708516 |
126 | MARK2 | 0.44472971 |
127 | PKN1 | 0.44143232 |
128 | EIF2AK3 | 0.43757120 |
129 | UHMK1 | 0.43274874 |
130 | MAPK4 | 0.43241242 |
131 | TLK1 | 0.42521838 |
132 | MOS | 0.42167624 |
133 | EPHB2 | 0.41625354 |
134 | PRKG2 | 0.40915463 |
135 | RAF1 | 0.40835665 |
136 | CDK18 | 0.40735748 |
137 | DYRK2 | 0.40592075 |
138 | TBK1 | 0.40485683 |
139 | ILK | 0.40304153 |
140 | PRKG1 | 0.39948483 |
141 | MARK3 | 0.39708482 |
142 | CDK15 | 0.39278222 |
143 | BLK | 0.38511938 |
144 | WNK4 | 0.37990318 |
145 | WEE1 | 0.37795175 |
146 | PRKD2 | 0.37069047 |
147 | STK11 | 0.36621648 |
148 | RET | 0.36467849 |
149 | SCYL2 | 0.36385395 |
150 | PTK2B | 0.33568493 |
151 | SGK1 | 0.33449214 |
152 | CDK11A | 0.33043639 |
153 | CSNK1A1 | 0.32275380 |
154 | TYRO3 | 0.32236929 |
155 | PRKCE | 0.31517750 |
156 | CAMK1 | 0.29833543 |
157 | FES | 0.28012108 |
158 | CAMK2B | 0.25595262 |
Rank | Gene Set | Z-score |
---|---|---|
1 | Synaptic vesicle cycle_Homo sapiens_hsa04721 | 4.35460671 |
2 | Collecting duct acid secretion_Homo sapiens_hsa04966 | 3.84202772 |
3 | Proteasome_Homo sapiens_hsa03050 | 3.22471995 |
4 | Endocrine and other factor-regulated calcium reabsorption_Homo sapiens_hsa04961 | 2.92065958 |
5 | Vibrio cholerae infection_Homo sapiens_hsa05110 | 2.40962383 |
6 | Citrate cycle (TCA cycle)_Homo sapiens_hsa00020 | 2.38229291 |
7 | Nicotine addiction_Homo sapiens_hsa05033 | 2.30346594 |
8 | Regulation of autophagy_Homo sapiens_hsa04140 | 2.20097643 |
9 | Complement and coagulation cascades_Homo sapiens_hsa04610 | 1.93982501 |
10 | Vitamin B6 metabolism_Homo sapiens_hsa00750 | 1.91131557 |
11 | Vasopressin-regulated water reabsorption_Homo sapiens_hsa04962 | 1.89446319 |
12 | Arrhythmogenic right ventricular cardiomyopathy (ARVC)_Homo sapiens_hsa05412 | 1.85682942 |
13 | GABAergic synapse_Homo sapiens_hsa04727 | 1.85228515 |
14 | Olfactory transduction_Homo sapiens_hsa04740 | 1.78799954 |
15 | Other glycan degradation_Homo sapiens_hsa00511 | 1.72404893 |
16 | Oxidative phosphorylation_Homo sapiens_hsa00190 | 1.69822461 |
17 | Glycosaminoglycan degradation_Homo sapiens_hsa00531 | 1.69395175 |
18 | Dopaminergic synapse_Homo sapiens_hsa04728 | 1.69162430 |
19 | Amphetamine addiction_Homo sapiens_hsa05031 | 1.65686797 |
20 | Phenylalanine, tyrosine and tryptophan biosynthesis_Homo sapiens_hsa00400 | 1.64665839 |
21 | Long-term potentiation_Homo sapiens_hsa04720 | 1.62716484 |
22 | Retrograde endocannabinoid signaling_Homo sapiens_hsa04723 | 1.56755749 |
23 | Circadian entrainment_Homo sapiens_hsa04713 | 1.51985164 |
24 | Morphine addiction_Homo sapiens_hsa05032 | 1.51932934 |
25 | Fatty acid degradation_Homo sapiens_hsa00071 | 1.49087153 |
26 | Insulin secretion_Homo sapiens_hsa04911 | 1.48559209 |
27 | PPAR signaling pathway_Homo sapiens_hsa03320 | 1.45294823 |
28 | Arginine and proline metabolism_Homo sapiens_hsa00330 | 1.41657292 |
29 | 2-Oxocarboxylic acid metabolism_Homo sapiens_hsa01210 | 1.37283828 |
30 | Cyanoamino acid metabolism_Homo sapiens_hsa00460 | 1.34834291 |
31 | Glyoxylate and dicarboxylate metabolism_Homo sapiens_hsa00630 | 1.33927930 |
32 | Phenylalanine metabolism_Homo sapiens_hsa00360 | 1.29825335 |
33 | Glutamatergic synapse_Homo sapiens_hsa04724 | 1.28861739 |
34 | Taurine and hypotaurine metabolism_Homo sapiens_hsa00430 | 1.28753459 |
35 | Primary bile acid biosynthesis_Homo sapiens_hsa00120 | 1.25877664 |
36 | Parkinsons disease_Homo sapiens_hsa05012 | 1.25505796 |
37 | Galactose metabolism_Homo sapiens_hsa00052 | 1.22516817 |
38 | Taste transduction_Homo sapiens_hsa04742 | 1.22475358 |
39 | Epithelial cell signaling in Helicobacter pylori infection_Homo sapiens_hsa05120 | 1.21008762 |
40 | Bile secretion_Homo sapiens_hsa04976 | 1.19889210 |
41 | Lysosome_Homo sapiens_hsa04142 | 1.19192269 |
42 | Terpenoid backbone biosynthesis_Homo sapiens_hsa00900 | 1.15492561 |
43 | Salivary secretion_Homo sapiens_hsa04970 | 1.12225826 |
44 | Thyroid cancer_Homo sapiens_hsa05216 | 1.11246465 |
45 | Prion diseases_Homo sapiens_hsa05020 | 1.10551914 |
46 | Rheumatoid arthritis_Homo sapiens_hsa05323 | 1.09626592 |
47 | Cholinergic synapse_Homo sapiens_hsa04725 | 1.08901361 |
48 | Longevity regulating pathway - multiple species_Homo sapiens_hsa04213 | 1.07181683 |
49 | Adrenergic signaling in cardiomyocytes_Homo sapiens_hsa04261 | 1.06068069 |
50 | Insulin signaling pathway_Homo sapiens_hsa04910 | 1.05582561 |
51 | Starch and sucrose metabolism_Homo sapiens_hsa00500 | 1.03190572 |
52 | GnRH signaling pathway_Homo sapiens_hsa04912 | 1.03148378 |
53 | Histidine metabolism_Homo sapiens_hsa00340 | 1.02527862 |
54 | Adipocytokine signaling pathway_Homo sapiens_hsa04920 | 1.01873552 |
55 | Carbon metabolism_Homo sapiens_hsa01200 | 1.01064170 |
56 | Cocaine addiction_Homo sapiens_hsa05030 | 1.00734295 |
57 | Fatty acid metabolism_Homo sapiens_hsa01212 | 0.99707824 |
58 | Gastric acid secretion_Homo sapiens_hsa04971 | 0.98888781 |
59 | Aldosterone synthesis and secretion_Homo sapiens_hsa04925 | 0.95543839 |
60 | Melanogenesis_Homo sapiens_hsa04916 | 0.95351651 |
61 | Glucagon signaling pathway_Homo sapiens_hsa04922 | 0.95167232 |
62 | Long-term depression_Homo sapiens_hsa04730 | 0.95035310 |
63 | Cardiac muscle contraction_Homo sapiens_hsa04260 | 0.92862399 |
64 | Nicotinate and nicotinamide metabolism_Homo sapiens_hsa00760 | 0.92439474 |
65 | Gap junction_Homo sapiens_hsa04540 | 0.91301277 |
66 | Tryptophan metabolism_Homo sapiens_hsa00380 | 0.91022114 |
67 | Calcium signaling pathway_Homo sapiens_hsa04020 | 0.90751832 |
68 | Glycosphingolipid biosynthesis - globo series_Homo sapiens_hsa00603 | 0.90262290 |
69 | Fructose and mannose metabolism_Homo sapiens_hsa00051 | 0.88575187 |
70 | Valine, leucine and isoleucine degradation_Homo sapiens_hsa00280 | 0.88102378 |
71 | Focal adhesion_Homo sapiens_hsa04510 | 0.87957416 |
72 | Phagosome_Homo sapiens_hsa04145 | 0.86318415 |
73 | Inflammatory mediator regulation of TRP channels_Homo sapiens_hsa04750 | 0.85069838 |
74 | Tyrosine metabolism_Homo sapiens_hsa00350 | 0.85011812 |
75 | Ascorbate and aldarate metabolism_Homo sapiens_hsa00053 | 0.82761297 |
76 | Sphingolipid metabolism_Homo sapiens_hsa00600 | 0.81473961 |
77 | Huntingtons disease_Homo sapiens_hsa05016 | 0.80453335 |
78 | Arginine biosynthesis_Homo sapiens_hsa00220 | 0.79393044 |
79 | Serotonergic synapse_Homo sapiens_hsa04726 | 0.79388989 |
80 | Dilated cardiomyopathy_Homo sapiens_hsa05414 | 0.78695445 |
81 | Sulfur metabolism_Homo sapiens_hsa00920 | 0.77935775 |
82 | Oxytocin signaling pathway_Homo sapiens_hsa04921 | 0.74836630 |
83 | Butanoate metabolism_Homo sapiens_hsa00650 | 0.74334098 |
84 | Biosynthesis of unsaturated fatty acids_Homo sapiens_hsa01040 | 0.72785969 |
85 | ECM-receptor interaction_Homo sapiens_hsa04512 | 0.72282235 |
86 | Renin secretion_Homo sapiens_hsa04924 | 0.71597145 |
87 | Vascular smooth muscle contraction_Homo sapiens_hsa04270 | 0.70838207 |
88 | Amoebiasis_Homo sapiens_hsa05146 | 0.69817098 |
89 | Alzheimers disease_Homo sapiens_hsa05010 | 0.69731798 |
90 | Glycosaminoglycan biosynthesis - heparan sulfate / heparin_Homo sapiens_hsa00534 | 0.68806289 |
91 | Pyruvate metabolism_Homo sapiens_hsa00620 | 0.67777121 |
92 | beta-Alanine metabolism_Homo sapiens_hsa00410 | 0.65724877 |
93 | Amyotrophic lateral sclerosis (ALS)_Homo sapiens_hsa05014 | 0.64149364 |
94 | Biosynthesis of amino acids_Homo sapiens_hsa01230 | 0.63617400 |
95 | Longevity regulating pathway - mammal_Homo sapiens_hsa04211 | 0.61926758 |
96 | RNA polymerase_Homo sapiens_hsa03020 | 0.60474874 |
97 | Tight junction_Homo sapiens_hsa04530 | 0.59041494 |
98 | Pancreatic secretion_Homo sapiens_hsa04972 | 0.58446971 |
99 | Ubiquinone and other terpenoid-quinone biosynthesis_Homo sapiens_hsa00130 | 0.58371788 |
100 | Oocyte meiosis_Homo sapiens_hsa04114 | 0.58165357 |
101 | Neuroactive ligand-receptor interaction_Homo sapiens_hsa04080 | 0.57998072 |
102 | Glycine, serine and threonine metabolism_Homo sapiens_hsa00260 | 0.57528342 |
103 | cAMP signaling pathway_Homo sapiens_hsa04024 | 0.57453997 |
104 | Alanine, aspartate and glutamate metabolism_Homo sapiens_hsa00250 | 0.57130677 |
105 | Glycerophospholipid metabolism_Homo sapiens_hsa00564 | 0.56858438 |
106 | Pentose and glucuronate interconversions_Homo sapiens_hsa00040 | 0.55732868 |
107 | SNARE interactions in vesicular transport_Homo sapiens_hsa04130 | 0.55445953 |
108 | Proximal tubule bicarbonate reclamation_Homo sapiens_hsa04964 | 0.54661035 |
109 | Glycosphingolipid biosynthesis - ganglio series_Homo sapiens_hsa00604 | 0.54197079 |
110 | Butirosin and neomycin biosynthesis_Homo sapiens_hsa00524 | 0.53362023 |
111 | Regulation of lipolysis in adipocytes_Homo sapiens_hsa04923 | 0.53189321 |
112 | Drug metabolism - cytochrome P450_Homo sapiens_hsa00982 | 0.52406798 |
113 | Mineral absorption_Homo sapiens_hsa04978 | 0.51713250 |
114 | Peroxisome_Homo sapiens_hsa04146 | 0.50971800 |
115 | Pertussis_Homo sapiens_hsa05133 | 0.50766449 |
116 | Fatty acid elongation_Homo sapiens_hsa00062 | 0.48853992 |
117 | AMPK signaling pathway_Homo sapiens_hsa04152 | 0.47643968 |
118 | Propanoate metabolism_Homo sapiens_hsa00640 | 0.45699226 |
119 | Pentose phosphate pathway_Homo sapiens_hsa00030 | 0.45683573 |
120 | ABC transporters_Homo sapiens_hsa02010 | 0.45494458 |
121 | AGE-RAGE signaling pathway in diabetic complications_Homo sapiens_hsa04933 | 0.45062861 |
122 | Thyroid hormone synthesis_Homo sapiens_hsa04918 | 0.44314483 |
123 | VEGF signaling pathway_Homo sapiens_hsa04370 | 0.43801670 |
124 | Arachidonic acid metabolism_Homo sapiens_hsa00590 | 0.41998865 |
125 | Amino sugar and nucleotide sugar metabolism_Homo sapiens_hsa00520 | 0.41315781 |
126 | Fat digestion and absorption_Homo sapiens_hsa04975 | 0.41150820 |
127 | Nitrogen metabolism_Homo sapiens_hsa00910 | 0.40640819 |
128 | ErbB signaling pathway_Homo sapiens_hsa04012 | 0.40172147 |
129 | Proteoglycans in cancer_Homo sapiens_hsa05205 | 0.39598599 |
130 | Endocytosis_Homo sapiens_hsa04144 | 0.38122906 |
131 | Folate biosynthesis_Homo sapiens_hsa00790 | 0.37991889 |
132 | Estrogen signaling pathway_Homo sapiens_hsa04915 | 0.37943696 |
133 | Circadian rhythm_Homo sapiens_hsa04710 | 0.37744121 |
134 | Ovarian steroidogenesis_Homo sapiens_hsa04913 | 0.37662731 |
135 | cGMP-PKG signaling pathway_Homo sapiens_hsa04022 | 0.37051776 |
136 | Cysteine and methionine metabolism_Homo sapiens_hsa00270 | 0.36613231 |
137 | Hypertrophic cardiomyopathy (HCM)_Homo sapiens_hsa05410 | 0.36144241 |
138 | Glycolysis / Gluconeogenesis_Homo sapiens_hsa00010 | 0.35076117 |
139 | Glycosaminoglycan biosynthesis - keratan sulfate_Homo sapiens_hsa00533 | 0.31391677 |
140 | Neurotrophin signaling pathway_Homo sapiens_hsa04722 | 0.26087514 |
141 | Metabolic pathways_Homo sapiens_hsa01100 | 0.25091249 |
142 | Thyroid hormone signaling pathway_Homo sapiens_hsa04919 | 0.24325424 |
143 | Insulin resistance_Homo sapiens_hsa04931 | 0.24047771 |